Sophia Genetics SA SOPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SOPH is a good fit for your portfolio.
News
-
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
-
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
-
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
-
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
-
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
-
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
-
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
Trading Information
- Previous Close Price
- $5.06
- Day Range
- $4.95–5.20
- 52-Week Range
- $2.13–7.37
- Bid/Ask
- $5.13 / $5.20
- Market Cap
- $337.28 Mil
- Volume/Avg
- 13,558 / 61,437
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.25
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 449
- Website
- https://www.sophiagenetics.com
Comparables
Valuation
|
Metric
|
SOPH
|
NORDH
|
NAUT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.18 | 2.52 | 1.21 |
Price/Sales | 5.25 | 5.64 | — |
Price/Cash Flow | — | 6,695.68 | — |
Price/Earnings
SOPH
NORDH
NAUT
Financial Strength
|
Metric
|
SOPH
|
NORDH
|
NAUT
|
|---|---|---|---|
Quick Ratio | 3.89 | 3.05 | 19.01 |
Current Ratio | 4.16 | 3.14 | 19.39 |
Interest Coverage | −140.23 | −1,368.75 | — |
Quick Ratio
SOPH
NORDH
NAUT
Profitability
|
Metric
|
SOPH
|
NORDH
|
NAUT
|
|---|---|---|---|
Return on Assets (Normalized) | −29.25% | −11.20% | −15.61% |
Return on Equity (Normalized) | −37.51% | −12.74% | −17.76% |
Return on Invested Capital (Normalized) | −35.84% | −11.92% | −19.72% |
Return on Assets
SOPH
NORDH
NAUT
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Sqzfrf | $40.6 Bil | |
VEEV
| Veeva Systems Inc Class A | Rytycsph | Whl | $32.6 Bil | |
SOLV
| Solventum Corp | — | Hnqrjm | $11.4 Bil | |
MTHRF
| M3 Inc | — | Jwwbp | $8.1 Bil | |
MTHRY
| M3 Inc ADR | — | Bbmlc | $8.1 Bil | |
PMCUF
| Pro Medicus Ltd | — | Gvkhdl | $7.6 Bil | |
HQY
| HealthEquity Inc | — | Skjyq | $6.9 Bil | |
RCM
| R1 RCM Inc | — | Jpbp | $5.2 Bil | |
DOCS
| Doximity Inc Class A | — | Tqsrcn | $4.5 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Fddm | $3.4 Bil |